North America Cardiac Leads Market Size, Share & Trends Analysis Report By Leads (Pacing Leads, Defibrillator Leads), By End Use (Hospitals, Ambulatory Surgery Centers), By Country (U.S., Canada, Mexico), And Segment Forecasts, 2025 - 2033

North America Cardiac Leads Market Summary

The North America cardiac leads market size was estimated at USD 1.82 billion in 2024 and is projected to reach USD 2.52 billion by 2033, growing at a CAGR of 3.70% from 2025 to 2033. The rising prevalence of cardiovascular diseases (CVDs) in the U.S., including heart failure and arrhythmias, is being driven by multiple factors, notably sedentary lifestyles, obesity, and associated comorbidities.

According to the America Heart Association, in January 2024, the U.S. reported 931,578 deaths linked to cardiovascular disease, nearly 3,000 higher than the previous year, with the age-adjusted death rate climbing to 233.3 per 100,000 people, reflecting a 4.0% increase. This escalating disease load is contributing to a higher number of patients requiring device-based cardiac interventions, thereby strengthening demand for pacing leads and defibrillator leads essential for effective rhythm management.

Atrial fibrillation continues to be widely underdiagnosed in the U.S., often progressing silently until symptoms become clinically significant. According to the American Medical Association article published in February 2025, more than 5 million American adults are estimated to be living with AFib, and this number is expected to exceed 12 million by 2030, reflecting a rapidly growing arrhythmia burden across the country. While the patient population expands, hospitals and electrophysiology centers are seeing elevated demand for device-based rhythm stabilization, including pacemakers, conduction-system pacing solutions, and implantable defibrillators. Since these systems rely on high-quality cardiac leads to ensure accurate sensing and consistent electrical therapy, the increasing prevalence of AFib is directly strengthening the need for advanced pacing and defibrillator lead technologies throughout the U.S. and broader North America cardiac leads industry.

North America Cardiac Leads Market Report Segmentation

This report forecasts revenue growth at the regional and country levels and provides an analysis of the latest industry trends in each sub-segment from 2021 to 2033. For this study, Grand View Research has segmented the North America cardiac leads market report based on lead, end use, and region:

• Leads Outlook (Volume in ‘000 Units; Revenue in USD Million, 2021 - 2033)
• Pacing Leads
• Standard RV/LV Leads
• Conduction System Pacing (CSP) / LBBAP Leads
• Defibrillator Leads
• Traditional Leads
• LV Leads
• End Use Outlook (Volume in ‘000 Units; Revenue in USD Million, 2021 - 2033)
• Hospitals
• Ambulatory Surgery Centers
• Others
• Country Outlook (Volume in ‘000 Units; Revenue in USD Million, 2021 - 2033)
• U.S.
• Canada
• Mexico

Please note The report will be delivered in 2-3 business days upon order notification. Show more